Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease

E.J. Wagena*, M.P.A. Zeegers, C.P. van Schayck, E.F.M. Wouters

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry

Psychology

Pharmacology, Toxicology and Pharmaceutical Science